Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
New data shows how specific drugs affect heart and kidney health.
Today's news focuses on how specific medications work for people with both heart and kidney issues. The strongest evidence comes from large trials looking at finerenone and semaglutide. These studies help clarify how these drugs affect blood pressure, blood sugar, and organ protection. The findings are important for understanding treatment options at different stages of kidney disease.
Dose-Exposure-Response Analysis of Finerenone on Serum Potassium and Cardiovascular Outcomes Among Patients With Heart Failure: Insights From FINEARTS-HF.
This analysis comes from a large randomized trial of 6,001 people with heart failure. It looked at how the dose of a drug called finerenone affected heart and kidney outcomes. The study found that the drug's benefits were linked to the dose and how well it was absorbed. This is a large trial, so the evidence is strong.
Changes in Metabolic and Blood Pressure Outcomes With Semaglutide Across Chronic Kidney Disease Stages: A Post Hoc Analysis of the FLOW Trial.
This is a follow-up analysis of a large randomized trial called FLOW. It looked at how a drug called semaglutide affected blood sugar, weight, and blood pressure in people with kidney disease. The study checked these effects across different stages of kidney damage. This is a large trial, so the evidence is strong.
Impact of CKD and Hemodialysis on Treatment of Severely Calcified Lesions: The ECLIPSE Trial
This large study looked at 2,001 people with hard, calcified spots in their heart arteries. It tested two ways to open these spots before placing a stent. The study found that kidney disease changes how well these treatments work. This is a big trial with strong evidence.
Comparison of an AI-enabled single-lead ECG monitor and point-of-care testing for detecting intradialytic hypokalemia.
This small study tested a new heart monitor that uses AI to check potassium levels in 29 dialysis patients. It compared this monitor to standard blood tests. The study was small and short, so it cannot prove the monitor works for everyone yet. It may help catch low potassium faster during dialysis.
Bleeding and Thromboembolic Outcomes Following GLP-1 Receptor Agonist Initiation in Patients With Type 2 Diabetes and Atrial Fibrillation Receiving Direct Oral Anticoagulants: A Target Trial Emulation.
This study looked at people with diabetes and an irregular heartbeat who take blood thinners. It checked if starting a GLP-1 drug changed their risk of bleeding or clots. The study used a method called target trial emulation to mimic a randomized test. It is an observational study, so it shows a link, not proof of cause.
Risk of cardiovascular events and mortality associated with LDL and non-HDL cholesterol levels after statin initiation for primary prevention: A multiregional cohort study.
This study looked at 185,237 people who started taking statins to prevent heart disease. It found that people who reached their cholesterol goals had fewer heart attacks and deaths. This is an observational study, so it shows a link but not proof of cause. The group did not have kidney disease, so the results may not apply to everyone.
Sex-Specific Mediators of Serum Uric Acid Reduction Following Laparoscopic Sleeve Gastrectomy: A Retrospective Longitudinal Study.
People who had weight loss surgery saw their uric acid levels drop. High uric acid is linked to kidney disease. This study followed 268 people for one year. It looked at how men and women differed. This is an observational study, so it shows a link, not proof of cause.
Dynamics of the Prevalence of Non-communicable Diseases in the Urban Double Cotonou - Abomey-Calavi (South of Benin).
This study looked at the spread of chronic diseases in two cities in Benin. It found that lifestyle changes are leading to more non-communicable diseases, including kidney issues. This is an observational study, so it shows a link, not proof of cause. It highlights the need for better prevention in these areas.
Association of finerenone plus tripterygium glycosides with proteinuria reduction in patients with diabetic kidney disease: a retrospective cohort study
This study looked at 203 people with diabetic kidney disease. It compared a drug called finerenone alone with finerenone plus a second drug. The group taking both drugs had less protein in their urine. This shows a link, but it is not proof that the second drug caused the change.
BIOMARCADORES URINÁRIOS NA DOENÇA RENAL CRÔNICA: CONTRIBUIÇÕES COMPLEMENTARES AO DIAGNÓSTICO E À AVALIAÇÃO PROGNÓSTICA – REVISÃO INTEGRATIVA
This review looked at urine tests that might spot kidney damage early. It suggests these markers could help doctors track how fast kidney disease gets worse. The study shows a link between these tests and kidney health, but it is not proof that the tests cause better care. It helps doctors see risks that standard blood tests might miss.
Preoperative SGLT2 Inhibitor Use Is Associated With Reduced 90-Day Complications and Lower Prolonged Opioid Use After Posterior Lumbar Fusion
This study looked at people taking a certain diabetes drug before back surgery. It found a link between taking the drug and fewer complications. It also found less need for pain pills. This shows a link, but it is not proof that the drug caused the better outcomes.
Longitudinal assessment of cognitive decline in hemodialysis patients: unveiling sex disparities.
This study followed 90 people on dialysis for two years to check their memory. It found that men and women may lose memory at different rates. This shows a link, but it does not prove that one sex causes the decline in the other.
Prevalence, Bacterial Spectrum and Risk Factors for Catheter-Related Bloodstream Infections (CRBSI) in Patients on Maintenance Hemodialysis in a Tertiary Care Hospital
This study tracked infections in dialysis patients over one year. It found that catheter infections are a serious risk. This shows a link between catheters and infection, but it is not proof of cause.
Nonlinear association between comorbidity burden and in-hospital mortality among adults hospitalized with acute kidney injury
This study looked at hospital records for people with sudden kidney injury. It found that having many other diseases raises the risk of dying in the hospital. This shows a link, not proof of cause.
Inpatient Erythropoiesis-Stimulating Agent Use and Anemia-Related Outcomes in Patients With Advanced Chronic Kidney Disease
This study checked what happens when kidney patients stop their anemia shots during a hospital stay. It looked at blood counts and other outcomes. This shows a link between stopping the drug and health changes, not proof of cause.
Pattern of Glomerulonephritis among Patients with Proteinuria Attending at a Tertiary Care Hospital in Bangladesh
This study examined kidney tissue from 184 patients with protein in their urine. It mapped the types of kidney inflammation found. This shows a link between protein and specific kidney diseases, not proof of cause.
Implementation of pharmacist‐led chronic kidney disease screening in Australian community pharmacies: feasibility and characteristics of the screened population
This study tested if pharmacists can screen for kidney disease in stores. It reports on the people who were screened. This shows a link between pharmacy visits and risk detection, not proof of cause.
Evaluation of Prescribing Patterns and Renal Dose Adjustment Practices in Chronic Kidney Disease: A Prospective Observational Study
Researchers watched how doctors prescribed medicine to 166 people with kidney disease over six months. They checked if doctors adjusted drug doses correctly for people whose kidneys filter slowly. This study shows what happens in real clinics, but it does not prove that these practices improve health. It is an observational study, so it shows a link, not proof of cause.
Clinical Presentation and Outcome of Acute Kidney Injury at a Tertiary Care Hospital in Bangladesh: A Retrospective Study
This study looked back at records of people with sudden kidney failure in a hospital in Bangladesh. It describes the causes and short-term outcomes for these patients. Because it is a retrospective observational study, it shows a link between factors and outcomes, but not proof of cause.
Serum uric acid and estimated glomerular filtration rate in working-age males: a 10-year longitudinal study of annual health check-up data from an occupational cohort in Japan
Researchers tracked kidney function in working-age men in Japan for 10 years. They found a link between high uric acid levels and slower kidney filtering. This is an observational study, so it shows a connection, not proof that uric acid causes kidney decline.